Category: Cardiovascular Devices
Global Cardiovascular Devices
-
Global ECG Patches and Holter Monitor Market - 2024 - 2031
... the field, increase in investments for early detection of arrhythmia, and advancements in the field of telemetry will help the market to grow during the forecast period. The ECG patch is a small device that ... Read More
-
Global Cardiac Troponin Market- 2023-2030
... troponin generally is a test that detects damage to the heart muscle. Troponin is a protein that occurs in the blood only when the heart muscle is damaged, as in a heart attack. Other reasons ... Read More
-
Global Interventional Cardiology Market - 2024-2031
... a medical specialty that uses a thin, flexible tube known as a catheter to repair damaged or weakened vessels, narrowed arteries, or other structural issues with the heart. Cardiac interventions frequently eliminate the need for ... Read More
-
2025 EEG, MEG, EKG Scans & Tests Global Market Size & Growth Report with Updated Analysis & Forecasts
... East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling electroencephalography (eeg), magnetoencephalography (meg), ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
... Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac ... Read More
-
Inferior Vena Cava (IVC) Filters
... Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Retrievable IVC Filters, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$1.0 ... Read More
-
Cardiac Rehabilitation Devices
... at a CAGR of 4.8% over the analysis period 2024-2030. Treadmill, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$1.2 Billion by the end of the ... Read More
-
Electrophysiology Devices
... CAGR of 8.1% over the analysis period 2024-2030. Electrophysiology Ablation Catheters, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$6.6 Billion by the end of the ... Read More
-
Heart Valve Repair and Replacement Devices
... reach US$40.9 Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. Transcatheter Surgery, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach ... Read More
-
Coronary Artery Bypass Grafts (CABG)
... Million by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Off-Pump CABG, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$109.1 Million ... Read More
-
Electrophysiology Ablation Catheters
... at a CAGR of 6.6% over the analysis period 2024-2030. Radiofrequency (RF) Ablation Catheters, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.9 Billion by the ... Read More
-
Embolic Protection Devices
... at a CAGR of 6.6% over the analysis period 2024-2030. Distal Filter, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Carotid Stents
... CAGR of 8.6% over the analysis period 2024-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$4.3 Billion by the end of the ... Read More
-
Ventricular Assist Devices
... at a CAGR of 15.6% over the analysis period 2024-2030. Left Ventricular Assist Devices (LVADs), one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$10.6 Billion by ... Read More
-
Coronary Stents
... CAGR of 5.4% over the analysis period 2024-2030. Drug Eluting Stents, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$9.6 Billion by the end of the ... Read More
-
Cardiology IT Workflow Solutions
... 2030, growing at a CAGR of 8.0% over the analysis period 2024-2030. Cloud Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$1.1 Billion by the ... Read More
-
Cardiovascular Information Systems
... at a CAGR of 6.0% over the analysis period 2024-2030. Web-based Cardiovascular Information Systems, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.4 Billion by the ... Read More
-
Cardiac Surgery Instruments
... at a CAGR of 5.4% over the analysis period 2024-2030. Forceps, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$957.4 Million by the end of the ... Read More
-
Cardiovascular Surgery Devices
... at a CAGR of 3.5% over the analysis period 2024-2030. Perfusion Disposables, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$2.1 Billion by the end of ... Read More
-
Transcatheter Heart Valves
... at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the ... Read More
-
Pediatric Interventional Cardiology Devices
... 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Congenital Heart Defect Closure Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.4 ... Read More
-
Congestive Heart Failure (CHF) Treatment Devices
... reach US$37.9 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Implantable Cardioverter Defibrillators, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and ... Read More
-
Patient Monitoring Devices
... at a CAGR of 7.5% over the analysis period 2024-2030. Blood Glucose Monitoring Device, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 Billion by the ... Read More
-
Cardiac POC Testing Devices
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More
-
Heart Pump Devices
... at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the ... Read More
Research Assistance
